Andros provides an integrated digital platform for life sciences and healthcare to streamline clinical trials and patient care. The platform collects real-time trial data, supports patient recruitment, and enables remote monitoring within a single ecosystem that can connect to existing systems while prioritizing security. It differentiates itself by offering end-to-end trial workflow tools with a focus on ease of use, seamless integration, and strict regulatory compliance, reducing administrative work compared with point solutions. The goal is to advance digital transformation in healthcare and clinical research by delivering practical tools that improve trial quality, efficiency, and patient outcomes.
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$58.4M
Headquarters
New York City, New York
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Medallion has acquired Andros, an NCQA-certified credentials verification organisation, bringing over a million providers across nearly 400 healthcare organisations and health plans onto a single credentialing platform. The acquisition makes Medallion the largest AI-native credentialing platform in the US. Andros, which has credentialed providers for health plans, health systems, provider groups, and telehealth companies since 2013, will gain access to Medallion's AI-assisted features. These include automated primary source collection, AI agents for provider outreach, and real-time status tracking. Medallion will continue serving health plans, health systems, provider groups, digital health companies, and telehealth organisations. Bailey Company served as financial adviser to Andros. Transaction terms were not disclosed.